A Case of Hypophosphatasia Started Enzyme Replacement Therapy Since Babyhood Stage
Open Access
Abstract
Background: Hypophosphatasia (HPP) is an inherited disease caused by low activity of tissue-nonspecific alkaline phosphatase. Dental characteristics include premature loss of primary teeth, enlarged pulp chambers, and enamel hypoplasia. Although enzyme replacement therapy with asfotase alfa was approved in 2015, there are few reports about the dental outcomes of this treatment. Case presentation: A 1-year-old girl referred to our hospital had already lost two primary teeth at the time of her initial visit. She started enzyme replacement therapy 6 days after birth, and genetic analysis later confirmed the diagnosis of HPP. At the age of 4 years and 7 months, 11 primary teeth had been lost, and some of the exfoliated teeth showed inflammatory root resorption or root fracture. There was also a history of abscess formation in a non-carious primary molar. Conclusions: This report suggests that early enzyme replacement therapy may prevent traditional tooth loss in patients with HPP. It also highlights the new challenges posed for dental professionals in providing infection control in large pulp cavities and receding periodontal tissue.Keywords
This publication has 60 references indexed in Scilit:
- The impact of enzyme replacement therapy on the oral health manifestations of hypophosphatasia among children: a scoping reviewEuropean Archives of Paediatric Dentistry, 2023
- Prenatal alcohol exposure can be determined from baby teeth: Proof of conceptBirth Defects Research, 2022
- Burosumab for Pediatric X-Linked HypophosphatemiaCurrent Osteoporosis Reports, 2021
- Treatment of hypophosphatasiaWiener Medizinische Wochenschrift, 2020
- Dental manifestations of hypophosphatasia in children and the effects of enzyme replacement therapy on dental status: A series of clinical casesClinical Case Reports, 2020
- Hypophosphatasia in Japan: ALPL Mutation Analysis in 98 Unrelated PatientsCalcified Tissue International, 2019
- Hypophosphatasia: From Diagnosis to TreatmentCurrent Rheumatology Reports, 2018
- Improvement of the skeletal and dental hypophosphatasia phenotype in Alpl−/− mice by administration of soluble (non-targeted) chimeric alkaline phosphataseBone, 2015
- Review of the dental implications of X-linked hypophosphataemic rickets (XLHR)Clinical Oral Investigations, 2015
- DEVELOPMENTAL PATTERN OF THE CHILD AS REFLECTED IN THE CALCIFICATION PATTERN OF THE TEETHArchives of Pediatrics & Adolescent Medicine, 1941